HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ocular surface reconstruction with cultivated limbal epithelium in a patient with unilateral stem cell deficiency caused by Epidermolysis bullosa dystrophica hallopeau-Siemens.

AbstractPURPOSE:
To report a case of partial limbal stem cell deficiency (LSCD) caused by epidermolysis bullosa dystrophica mutilans Hallopeau-Siemens treated by transplantation of autologous ex vivo expanded limbal epithelium.
METHODS:
Review of the clinical findings of an 11.5-year-old boy with unilateral LSCD and epidermolysis bullosa dystrophica who underwent ocular surface reconstruction in the right eye with autologous on intact human amniotic membrane cultivated limbal epithelial cells.
RESULTS:
Twenty-eight months after reconstruction, the corneal surface is clear, smooth, and stable showing no signs of LSCD recurrence. Three subconjunctival bevacizumab (Avastin) injections reduced the recurrent growth of symblepharon and corneal vascularization. The visual acuity has increased from hand motion to 20/50.
CONCLUSION:
Autologous transplantation of cultivated human limbal epithelial cells on intact human amniotic membrane can be a safe and effective method for corneal surface reconstruction in LSCD caused by recessive epidermolysis bullosa dystrophica.
AuthorsMelissa Thanos, Mikk Pauklin, Klaus-P Steuhl, Daniel Meller
JournalCornea (Cornea) Vol. 29 Issue 4 Pg. 462-4 (Apr 2010) ISSN: 1536-4798 [Electronic] United States
PMID20164760 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Cell Culture Techniques
  • Child
  • Corneal Diseases (etiology, physiopathology, surgery)
  • Epidermolysis Bullosa Dystrophica (complications)
  • Epithelial Cells (physiology, transplantation)
  • Epithelium, Corneal (cytology, physiopathology)
  • Humans
  • Limbus Corneae (cytology)
  • Male
  • Recovery of Function
  • Stem Cell Transplantation
  • Stem Cells (pathology)
  • Transplantation, Autologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: